LFWD
BEARISHAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Trades at a low multiple of sales, but value is eroded by negative earnings and shrinking revenue.
- Low P/S ratio
- P/B near 1.19
- Negative Forward P/E
- No Graham Number available due to lack of earnings
Growth metrics are deeply negative, indicating a shrinking business.
- Year-over-year EPS growth is technically positive (less negative)
- Revenue growth -32.70%
- Q/Q Revenue growth -32.66%
Long-term historical trend is one of near-total value destruction.
- 5Y Change: -96%
- 1Y Change: -60.6%
- Consistent earnings misses
Piotroski score of 1/9 is a strong deterministic signal of financial instability.
- Manageable Debt/Equity
- Piotroski F-Score 1/9
- Quick Ratio 0.69 (Liquidity risk)
- ROE -146.12%
Non-dividend paying company.
- No dividend paid
- No dividend history
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for LFWD and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd.
Primary
|
-96.0% | -88.2% | -60.6% | -26.0% | -1.6% | -4.2% |
|
DARE
Daré Bioscience, Inc.
Peer
|
-91.0% | -85.0% | -38.6% | -21.2% | +15.7% | -2.8% |
|
ICCM
IceCure Medical Ltd
Peer
|
-97.0% | -71.2% | -71.9% | -62.9% | -51.7% | +7.7% |
|
AYTU
Aytu BioPharma, Inc.
Peer
|
-98.4% | -24.2% | +61.7% | +2.7% | +6.7% | +1.5% |
|
KYNB
Kyntra Bio, Inc.
Peer
|
-98.6% | -98.5% | +10.3% | -32.0% | +0.7% | +2.3% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd.
|
BEARISH | $24.87M | - | -146.1% | -90.4% | $6.57 | |
|
DARE
Daré Bioscience, Inc.
|
BEARISH | $25.77M | - | -% | -% | $1.77 | Compare |
|
ICCM
IceCure Medical Ltd
|
BEARISH | $26.25M | - | -188.8% | -% | $0.32 | Compare |
|
AYTU
Aytu BioPharma, Inc.
|
NEUTRAL | $27.51M | - | -50.2% | -20.5% | $2.7 | Compare |
|
KYNB
Kyntra Bio, Inc.
|
BEARISH | $29.02M | - | -% | 2848.6% | $7.17 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-11 | LYNCH JEANNINE | Officer | Stock Award | 50,000 | - |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning LFWD from our newsroom.